What is the pathophysiology of dengue fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Dengue Fever

Dengue pathogenesis is fundamentally driven by an aberrant host immune response that triggers a cytokine storm, leading to vascular permeability, plasma leakage, thrombocytopenia, and coagulopathy—rather than direct viral cytopathic effects alone. 1, 2

Viral Transmission and Initial Infection

  • Dengue virus is transmitted by Aedes species mosquitoes, primarily Aedes aegypti, with an incubation period of 4-8 days following the bite 3, 4
  • The virus replicates in target cells including monocytes, endothelial cells, and hepatocytes, with viral RNA detectable in serum from approximately 2 days before to 1 week after illness onset 3
  • Most dengue infections (the majority) remain asymptomatic, but symptomatic cases range from mild febrile illness to life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) 3, 4

The Cytokine Storm: Central Pathogenic Mechanism

The hallmark of severe dengue is an imbalanced cytokine response—a "cytokine storm"—characterized by excessive pro-inflammatory cytokines overwhelming anti-inflammatory mediators. 1

  • Dengue infection triggers elevated levels of IL-6, IL-8, and tumor necrosis factor (TNF), which are strongly associated with disease severity 3
  • IL-8 levels during early infection are significantly elevated in patients who develop bleeding complications and hepatitis 5
  • IL-6 acts synergistically with IL-8 to cause bleeding in patients with plasma leakage, and may drive production of anti-platelet autoantibodies and elevated tissue plasminogen activator (tPA) levels 5, 2
  • The cytokine profile suggests a T-helper 2 (Th2) response pattern during infection 5

Vascular Permeability and Plasma Leakage

Increased vascular permeability leading to plasma leakage is the defining pathophysiologic feature that distinguishes severe dengue from uncomplicated disease. 1, 2

  • Cytokines act on endothelial cells to disrupt adherens junctions, causing increased vascular permeability 1
  • The dengue virus itself, along with antibodies to viral antigens (particularly NS1), can directly trigger capillary leakage 2, 6
  • Endothelial cell infection and dysfunction result from both direct viral effects and immune-mediated damage 2
  • Plasma leakage, if uncompensated, leads to hemoconcentration, hypovolemic shock, and ultimately dengue shock syndrome affecting 15% of pregnant women compared to 5% of non-pregnant individuals 3

Thrombocytopenia and Hemorrhagic Manifestations

  • Platelets are destroyed by cross-reactive anti-platelet autoantibodies generated during infection 2, 6
  • Thrombocytopenia results from immune-mediated destruction rather than direct viral effects on megakaryocytes 3, 2
  • Hemorrhagic manifestations arise from the combined effects of thrombocytopenia, endothelial dysfunction, and coagulopathy 2

Coagulopathy and Hemostatic Dysfunction

  • Both coagulation and fibrinolysis systems are activated following dengue infection 2
  • An imbalance between coagulation and fibrinolysis activation increases the likelihood of severe hemorrhage in DHF/DSS 2
  • In profound shock, disseminated intravascular coagulation (DIC) develops with multiple micro-thromboses leading to organ failure 1
  • IL-6 overproduction contributes to deficiency in coagulation factors and elevated tPA levels 2

Antibody-Dependent Enhancement (ADE)

  • Secondary infection with a different dengue serotype is strongly associated with more severe disease through ADE mechanisms 2, 6
  • Fcγ receptor-mediated ADE results in enhanced viral replication and increased cytokine release from immune cells 6
  • Pre-existing cross-reactive antibodies from prior infection facilitate viral entry into monocytes and macrophages, paradoxically increasing viral load 6

T Cell-Mediated Immunopathology

  • Dengue infection induces transient immune aberrations including CD4/CD8 ratio inversion 2
  • Memory cross-reactive T cells from prior heterologous dengue infection may produce altered cytokine responses, contributing to detrimental immune activation 6
  • Higher frequencies of dengue-specific TNFα, IFNγ, and IL-2-producing T cells correlate with subclinical rather than symptomatic secondary infection, suggesting protective versus pathogenic immune profiles 7

Hepatocyte Involvement and Liver Damage

  • Dengue virus infects hepatocytes, causing apoptosis and cellular dysfunction 2
  • Cell stress and liver damage contribute to the severe clinical course, particularly in pregnant women 3
  • Hepatomegaly is recognized as a danger sign requiring immediate medical attention 8

Autoimmunity

  • Dengue infection generates autoantibodies against viral NS1 antigen, prM, and E proteins that cross-react with self-antigens including plasminogen, integrin, and platelet cells 6
  • Anti-endothelial cell autoantibodies contribute to vascular dysfunction 2

Viral and Host Genetic Factors

  • Genomic variation of dengue virus and subgenomic flavivirus RNA (sfRNA) can suppress host immune responses, influencing disease severity 6
  • Host genetic polymorphisms and background are key factors driving cytokine storm production 1, 6
  • Displacement of viral genotypes in populations affects disease patterns 1

Critical Clinical Correlation

Warning signs appear around days 3-7 of illness during defervescence and include persistent vomiting, abdominal pain/tenderness, clinical fluid accumulation, mucosal bleeding, lethargy/restlessness, hepatomegaly, and hematocrit rise with concurrent thrombocytopenia. 8, 4

  • These warning signs directly reflect the underlying pathophysiology: plasma leakage (hemoconcentration), thrombocytopenia (immune destruction), bleeding (coagulopathy), and organ involvement (hepatomegaly) 8
  • Early recognition and appropriate fluid management can reduce case-fatality rates to <0.5% in hospitalized patients 3, 8

Common Pitfall

The absence of correlation between viral load and disease severity underscores that host immune response, not viral burden alone, drives severe dengue pathogenesis—making immunomodulation a potential therapeutic target rather than solely antiviral approaches. 1

References

Research

Immunopathogenesis of dengue virus infection.

Journal of biomedical science, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Danger Signs of Dengue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.